News chronological

Showing 8 items before 1166309

Filters Applied:

  • Channel A
  • Keyword: "drug-approval" (~33 currently found)

YOUTUBE (NewsNation) - New pancreatic cancer drug gives patients 'tremendous message for hope': Doctor

Click to play Video
▶️

Earlier this week, the FDA approved a groundbreaking new drug for advanced pancreatic cancer. Agency officials announced it gave the pill, daraxonrasib, approval more than six months ahead of a target date. Dr. Omer Awan, a senior public health contributor for Forbes, joins "NewsNation Live" to discuss the landmark medication. #pancreaticcancer #drug #fda Get a fast-paced look at the latest from the border to Main Street to the White House on "NewsNation Live." Weekends starting at 10a/9C Saturdays and 11a/10C Sundays. #NewsNationLive NewsNation is your source for fact-based, unbiased news for all Americans.

How much earlier than the target date did the FDA approve the drug daraxonrasib?
Agency officials announced that the drug received approval more than six months ahead of its target date.
Q&A ID e799eceb-c389-4c45-8a88-bf6e00e1047e
What new drug did the FDA recently approve for the treatment of advanced pancreatic cancer?
The FDA approved a groundbreaking new pill called daraxonrasib for patients with advanced pancreatic cancer.
Q&A ID 4e1eb680-19f2-4907-a904-6a835ff5feb1
Keywordspancreatic-cancercancerfdadaraxonrasibmedical-breakthroughhealthcarehealthbiotechpharmaceuticalspharmasciencepublic-healthtreatmentdrug-approvalmedical-innovationmedical-researchnewsnationoncologycancer-treatment

AMERICANGREATNESS (Thaddeus G. McCotter) - Save American Lives and Prosperity by Cutting the FDA Bureaucracy

By statute, the approval process of the Food and Drug Administration (FDA) is to determine the safety and effectiveness of a new drug. If both […] Source

Keywordsfdabureaucracyregulationus-policyhealthcaredrug-approvalfda-regulationsgovernment-policycommerceeconomyconsumer-protectionhealthscienceusaderegulationadministrative-statepolicypharmaceuticalpublic-healthefficiency

THEAMERICANCONSERVATIVE (Joseph Addington) - FDA Commissioner Makary Resigns Amid Controversy

State of the Union: The outgoing agency head had angered pharma companies, pro-life Republicans, and vaping lobbyists. The post FDA Commissioner Makary Resigns Amid Controversy appeared first on The American Conservative .

The head of the Food and Drug Administration (FDA), Marty Makary, resigned Tuesday after leading the agency for just 13 months. Makary’s tenure at the FDA was marked by significant controversy, as he angered a number of political constituencies. Makary was elevated to head the FDA by President Donald Trump as part of the administration’s embrace of the Make America Healthy Again movement, represented by Health Secretary Robert F. Kennedy Jr. His time at the FDA saw a significant exodus of agency officials and employees, which created turmoil in the agency’s drug review program and frustrated pharmaceutical companies waiting for regulatory approval for their products.  He also angered pro-life Republicans, who accused him of…Open

Keywordsmarty-makaryfdatrumprfk-jrhealthcaremake-america-healthy-againpharmaceuticalsmifepristonepro-lifevapinge-cigaretteskyle-diamantasdrug-approvalus-politicswashington-dcregulatory-affairsmedical-policyhealth-administrationgovernment-resignation

JUSTTHENEWS (Natalia Mittelstadt) - Moderna says FDA reversing course, will review mRNA flu shot

“Pending FDA approval, we look forward to making our flu vaccine available later this year so that America’s seniors have access to a new option to protect themselves against flu,” Moderna CEO Stéphane Bancel said

Keywordsmodernafdamrnaflu-vaccinebiotechhealthcarevaccinationusamedical-researchtechnologydrug-approvalgovernmenthealth-policyimmunizationmedicinerfk-jrwashington-dcpharmaceuticalsscience